CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through the following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants. The Human Medicine division manufactures and supplies pharmaceuticals, pharmaceutical raw materials and functional health products. The company was founded on December 28, 1995 and is headquartered in Hwaseong-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company